期刊
CLINICAL GENETICS
卷 93, 期 6, 页码 1131-1140出版社
WILEY
DOI: 10.1111/cge.13139
关键词
genetics; Leigh syndrome; neurology; therapy and pre-clinical research
资金
- NSFC [31270967, 31571407]
- RGC/GRF [HKU17113816, 17120517]
Leigh syndrome (LS) is an inherited mitochondrial encephalopathy associated with gene mutations of oxidative phosphorylation pathway that result in early disability and death in affected young children. Currently, LS is incurable and unresponsive to many treatments, although some case reports indicate that supplements can improve the condition. Many novel therapies are being continuously tested in pre-clinical studies. In this review, we summarize the genetic basis of LS, current treatment, pre-clinical studies in animal models and the management of other mitochondrial diseases. Future therapeutical strategies and challenges are also discussed.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据